TwinBeech Capital’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,289	Closed	-$137K	–	748
2025 Q4	$137K	Buy	+15,289	New	+$210K	0.01%	551
2025 Q3	–	Sell	-137,756	Closed	-$1.29M	–	750
2025 Q2	$1.29M	Buy	+137,756	New	+$1.13M	0.03%	381
2024 Q4	–	Sell	-175,023	Closed	-$3.6M	–	832
2024 Q3	$3.6M	Buy	175,023 +75,071	+75%	+$1.73M	0.07%	312
2024 Q2	$2.24M	Buy	+99,952	New	+$2.38M	0.04%	319
2024 Q1	–	Sell	-17,014	Closed	-$519K	–	773
2023 Q4	$519K	Sell	17,014 -82,266	-83%	-$2.36M	0.01%	548
2023 Q3	$3.14M	Buy	99,280 +61,952	+166%	+$2.4M	0.06%	335
2023 Q2	$1.52M	Sell	37,328 -121,951	-77%	-$4.95M	0.03%	412
2023 Q1	$5.94M	Sell	159,279 -5,081	-3%	-$199K	0.12%	214
2022 Q4	$5.73M	Buy	164,360 +67,890	+70%	+$3.23M	0.11%	226
2022 Q3	$5.4M	Buy	+96,470	New	+$5.98M	0.14%	175